the overall 24-item PRECIS PRO (Cronbach's alpha= 0.942) and individual domains (Cronbach's alphas: 0.743-0.873). Intraclass correlation coefficients were 0.78 for the overall 24-item PRECIS PRO and ranged from 0.49-0.74 for individual domains. Finally, discriminant validity testing confirmed there were significant differences between the patient group and the control group in each of the 5 domains of the revised 24-item PRECIS PRO (p<0.0001 Background: Neurological soft signs (NSS) are minor ('soft') neurological abnormalities in sensory and motor performance, which are frequently reported in patients with schizophrenia at any stage of their illness. It has been demonstrated that NSS vary in the clinical course of the disorder: Longitudinally NSS seem to decrease in parallel with remission of psychopathological symptoms, an effect which mainly applies to patients with a remitting course. However, these findings are mainly based on patients with a first episode of the disorder and the course of NSS in patients with chronic schizophrenia and persisting symptoms is rather unknown. Methods: Therefore, we investigated 21 patients with chronic schizophrenia (duration of illness: 22.8 years ± 11.5) twice with a follow-up time interval of 7 years. Baseline and endpoint NSS scores were evaluated by the Heidelberg Scale, established instruments were used to rate psychopathological symptoms and neuropsychological performance. Results: Results show a significant increase of the NSS subscales "motor coordination" and "integrative functions" with stable positive and negative symptoms, including apathy, as well as chlorpromazine equivalents. Along with this, neuropsychological parameters as verbal memory, verbal fluency and cognitive flexibility deteriorate significantly. Regression analyses show that the TMT B performance/cognitive flexibility and the SANS global score/negative symptoms at baseline are strong predictors for NSS increase at follow-up. Discussion: These results illustrate a significant aggravation of NSS in patients with chronic schizophrenia over time, while psychopathological symptoms remain stable. In addition, cognitive performance is deteriorating as well, with cognitive flexibility together with negative symptoms as strongest predictors for NSS changes.
T67. NEUROLOGICAL SOFT SIGNS IN
Background: Neurological soft signs (NSS) are minor ('soft') neurological abnormalities in sensory and motor performance, which are frequently reported in patients with schizophrenia at any stage of their illness. It has been demonstrated that NSS vary in the clinical course of the disorder: Longitudinally NSS seem to decrease in parallel with remission of psychopathological symptoms, an effect which mainly applies to patients with a remitting course. However, these findings are mainly based on patients with a first episode of the disorder and the course of NSS in patients with chronic schizophrenia and persisting symptoms is rather unknown. Methods: Therefore, we investigated 21 patients with chronic schizophrenia (duration of illness: 22.8 years ± 11.5) twice with a follow-up time interval of 7 years. Baseline and endpoint NSS scores were evaluated by the Heidelberg Scale, established instruments were used to rate psychopathological symptoms and neuropsychological performance. Results: Results show a significant increase of the NSS subscales "motor coordination" and "integrative functions" with stable positive and negative symptoms, including apathy, as well as chlorpromazine equivalents. Along with this, neuropsychological parameters as verbal memory, verbal fluency and cognitive flexibility deteriorate significantly. Regression analyses show that the TMT B performance/cognitive flexibility and the SANS global score/negative symptoms at baseline are strong predictors for NSS increase at follow-up. Discussion: These results illustrate a significant aggravation of NSS in patients with chronic schizophrenia over time, while psychopathological symptoms remain stable. In addition, cognitive performance is deteriorating as well, with cognitive flexibility together with negative symptoms as strongest predictors for NSS changes. (UPSA-B) . We conducted linear regressions to predict functional outcome considering demographic, intellectual, and cognitive variables, as well as the interaction between cognition and IQ in participants with SZ and HC separately. Results: Participants with SZ had worse cognitive performance and premorbid IQ, and poorer functional outcome compared to HC. For the prediction of UPSA-B, the regression model that included cognition and IQ as predictors and age and parental SES as covariates was significant in SZ (F(4, 124) = 8.473, p < .001, Adj. R 2 = .189), with the both variables showing significant main effects: IQ (β = .311, t = 3.324, p = .001) and cognition (β = .216, t = 2.630, p = .0010). When we included the IQ x cognition interaction (F(5, 123) = 7.035, p < .001, Adjusted R 2 = .191), it did not significantly improve the model (F = 1.224, p = 0.27), and the interaction was not significant (β = -.11, t = -1.106, p = .27). In HC, the regression model with only main effects was similar to what was seen in SZ (F(4,313) = 27.62, p < .001, Adj. R 2 = .25), with main effects of IQ (β = .239, t = 4.418, p < .001) and cognition (β = .349, t = 6.891, p < .001) (Figure 1 ). However, when we included the IQ x cognition interaction (F(5,312) = 24.15, p < .001, Adjusted R 2 = .27), the interaction was significant (β = -.139, t = -2.801, p = .005) and accounted for a significant increase in variance over and above the other main effects (F = 7.8452, p = .005). Discussion: In SZ, both higher IQ and better cognitive performance were independent predictors of better functioning. However, in HC, functionality was predicted by the interaction between IQ and cognition, with the form of the interaction suggesting that for HC participants with higher IQ, there was less effect of cognition on predicting better functioning. Conversely, in HC with lower premorbid IQ, better cognitive performance has a stronger effect in predicting better functioning. The fact that both IQ and cognition had independent relationships to functional outcome in SZ could help explain the limited clinically significant results found in previous studies of cognitive remediation and psychosocial interventions that did not also consider the impact of premorbid IQ. Future studies could focus on early interventions to prevent functional impairments through the stimulation of early intellectual development.
T68. DIFFERENT INFLUENCES OF

